What Happened?
Redwood City, AK-based Ambys-Medicines Appointed Jeffrey Tong as Chief Executive Officer
About the Company
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and gain-of-function drug therapy, to meet the urgent need for treatments that have the potential to restore liver function and prevent the progression to liver failure across multiple liver diseases that are untreatable or poorly treated today. Ambys was launched in 2018 by Third Rock Ventures and Takeda Pharmaceuticals with $140M in starting capital and is headquartered in South San Francisco, Calif.
About the Person
Jeffrey Tong is Chief Executive Officer at Ambys Medicines. Previously, Jeffrey held various senior HR leadership roles in the industry.
Info Source
News
Short Profile